Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Center for Medicine after the Holocaust Announces Supplement for Health Professions to the Declaration of the Stockholm International Forum on the Holocaust
- 9/19/2017 10:00:00 AM
- The Center for Medicine after the Holocaust (CMATH) today announced the Galilee Declaration, which affirms the Declaration of the Stockholm International Forum on the Holocaust and also supplements it for health professions.
- J.Lo and Saks Fifth Avenue partner through Key to the Cure to support cancer research
- 9/19/2017 1:47:21 AM
- Jennifer Lopez - singer, actress, dancer, fashion designer and one of the world’s most recognized celebrities - is the official campaign ambassador of the 2017 Key to the Cure, funding cancer research at the Translational Genomics Research Institute (TGen).
- Samsung Presents Clinical Usability of its Ultrasound Imaging Technology at ISUOG 2017
- 9/18/2017 2:17:45 AM
- Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, is hosting a number of seminars at the 27th World Congress of the International Society of Ultrasound in Obstetrics & Gynecology (ISUOG) in Vienna.
- Efficacy of Philips’ Stellarex* .035” low-dose drug-coated balloon demonstrated in clinical trial at two years
- 9/15/2017 11:22:23 AM
- Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating the efficacy of Philips Spectranetics’ Stellarex.035” drug-coated balloon (DCB) for peripheral arterial disease (PAD) in comparison to uncoated balloon angioplasty.
- New Study shows that Genomic Profiling can help Improve Treatment of Brain Tumors in Children
- 9/15/2017 10:34:24 AM
- “This study further demonstrates that genomic profiling can be readily integrated into the routine clinical workflow for children with brain tumors,” says corresponding author Shakti Ramkissoon, associate medical director at Foundation Medicine, a genomic profiling company based in Cambridge, MA.
- Infants with congenital Zika virus syndrome suffer serious visual impairment
- 9/14/2017 8:30:37 AM
- Although one of the most serious consequences of the Zika virus (ZIKV) in infants is microcephaly, there is a broad collection of anomalies now known as congenital Zika syndrome (CZS).
- Trial Compares Laparoscopic and Open Surgeries for Pancreatic Cancer
- 9/14/2017 7:56:55 AM
- The procedure is used to treat tumors located in the head of the pancreas and adjacent areas, where approximately 75% of pancreatic cancer tumors occur. In the 64-patient trial, which was carried out at GEM Hospital and Research Center, in India, showed overall complications and pathological outcomes did not differ, but laparoscopy offered reduced blood loss, decreased blood …
- “Florencia,” An Amazon Best-Selling Book is Free For One More Day (09/15/2017)
- 9/14/2017 6:00:00 AM
- Best Seller Publishing announces the release of John Mullen and Douglas Bowman’s new book, “Florencia - An Accidental Story.” It will be available for free download in the Amazon Kindle Store for one more day on September 15th.
- Battling Lyme Disease with Cutting Edge Testing Techniques
- 9/12/2017 11:36:30 AM
- In August, national media outlets published reports of experimental blood tests that showed promise for identifying early cases of Lyme disease. Early stage detection of the infection in people has traditionally been a challenge, as existing blood tests are known to frequently miss infections in the first few weeks.
- P&R Dental Strategies’ Data Used in Pediatric Dental Radiograph Use Study
- 9/12/2017 11:00:00 AM
- P&R Dental Strategies, LLC, the premier dental insights company delivering customized, actionable business intelligence to support a variety of dental payer objectives, today announced their co-authorship and contribution of data for a recent study on adherence to guidelines when prescribing dental radiographs for patients under age 18.
- Best Selling Book, “Florencia,” Is Now Free on Amazon for 5 Days (until 09/15/2017)
- 9/11/2017 6:00:00 AM
- Best Seller Publishing announces the release of John Mullen and Douglas Bowman’s new book, “Florencia - An Accidental Story.” It will be available for free download in the Amazon Kindle Store on September 11th.
- Cholesterol-Lowering Drugs May Help Patients with Cirrhosis
- 9/7/2017 10:28:33 AM
- In a new Alimentary Pharmacology & Therapeutics analysis of data from the Danish National Patient Registry, patients with cirrhosis of the liver due to alcohol had a 43% lower risk of dying prematurely than patients not on statins.
- Idylla™ Respiratory (IFV-RSV) Panel receives 510(k) clearance by US FDA
- 9/5/2017 9:28:07 AM
- Janssen Diagnostics, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, today announced that the United States Food and Drug Administration has granted 510(k) clearance for the Idylla™ Respiratory (IFV-RSV) Panel, a diagnostic test developed by Janssen Diagnostics scientists in partnership with Biocartis Group NV.
- Study suggests simple way to predict preterm births
- 9/4/2017 8:02:17 AM
- Up to 18 percent of babies born worldwide arrive before they are full-term, defined as 37 weeks of gestation. About 1 million of those babies do not survive, and those who do can face developmental problems such as impaired vision or hearing, defects in the heart or lungs, or cognitive impairments.
- XARELTO® (rivaroxaban) Significantly Reduced Major Cardiovascular Events in Patients with Stable Coronary and Peripheral Artery Disease in Pivotal Phase 3 Study
- 8/29/2017 10:13:29 AM
- o XARELTO ® vascular dose (2.5 mg twice daily) plus aspirin 100 mg once daily reduced the combined risk of cardiovascular death, stroke and heart attack by 24% compared to aspirin alone o Significantly fewer major amputations and major adverse limb events noted in subgroup analysis of patients with stable peripheral artery disease treated with combination regimen of …
- U.S. FDA and European Medicines Agency Accept Regulatory Submissions for BOSULIF® (bosutinib) for the Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia
- 8/29/2017 10:03:50 AM
- Pfizer Inc. (NYSE:PFE) and Avillion LLP today announced that a supplemental New Drug Application (sNDA) for BOSULIF® (bosutinib) has been accepted for filing and granted Priority Review by the U.S.
- Philips supports global transformation of pathology with two new fully digitized labs in Austria
- 8/29/2017 9:55:08 AM
- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the continued momentum of its cutting-edge pathology diagnostics with the successful transformation of two fully digital pathology labs in Austria.
- ACD/Labs Collaborates with Pearson to Improve Student Achievement in Chemistry
- 8/29/2017 9:00:00 AM
- ACD/Labs, an informatics company that develops and commercializes solutions in support of chemical and pharmaceutical R&D, today announced a collaboration with Pearson, the world’s learning company, which now leverages ACD/Labs’ Nuclear Magnetic Resonance (NMR) tools to support its Mastering Chemistry course.
- Studies Reveal How Shingles Vaccine Should Be Used in Arthritis Patients
- 8/28/2017 10:32:47 AM
- New research indicates that the live varicella-zoster vaccine—which is given to protect against shingles—elicits robust immune responses in patients when administered several weeks prior to the start of treatment with the arthritis drug tofacitinib.
- FDA warns US Stem Cell Clinic of significant deviations
- 8/28/2017 10:11:34 AM
- The U.S. Food and Drug Administration today posted a warning letter issued to US Stem Cell Clinic of Sunrise, Florida, and its Chief Scientific Officer Kristin Comella for marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice requirements, including some that could impact the sterility of their products, …
